Overactive bladder treatments in early phase clinical trials

Author： Colli Enrico   Digesu Giuseppe Alessandro   Olivieri Lorenza  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.16, Iss.7, 2007-06, pp. : 999-1007

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overactive bladder treatments prove their worth

By  

Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Overactive bladder treatments prove their worth

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 567, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The medical treatment of overactive bladder, including current and future treatments

By Athanasopoulos Anastasios   Cruz Francisco  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 7, 2011-05 ,pp. : 1041-1055

Informa Healthcare

Access to resources Recommend Favorite

An Urn Model for Odds-Ratio-Based Response-Adaptive Phase III Clinical Trials for Two or More Treatments

By Basak Gopal  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 838-856

Taylor & Francis Ltd

Access to resources Recommend Favorite

Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence

By Sacco Emilio   Bientinesi Riccardo   Tienforti Daniele   Racioppi Marco   Gulino Gaetano   D'Agostino Daniele   Vittori Matteo   Bassi Pierfrancesco  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 4, 2014-04 ,pp. : 433-448

Informa Healthcare

Access to resources Recommend Favorite